The global neuronavigation systems industry is anticipated to reach US$ 4794.5 million in value by 2032, up from US$ 2120.0 million in 2022, with a CAGR of 7.7%. The neuronavigation systems market is ...
A drug developed at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has been shown to extend survival for patients with glioblastoma, the most common primary brain ...
LONDON--(BUSINESS WIRE)--The global neuronavigation systems market is expected to grow at a CAGR of almost 6% during 2020-2024, according to the latest market research report by Technavio. The report ...
Although 12 million people in India suffer from epilepsy, it still remains a debilitating issue due to the high social stigma and huge treatment gap compared to the western world. According to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results